A detailed history of Quantamental Technologies LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 18,519 shares of VIR stock, worth $130,188. This represents 0.16% of its overall portfolio holdings.

Number of Shares
18,519
Previous 11,636 59.15%
Holding current value
$130,188
Previous $285,000 39.3%
% of portfolio
0.16%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$9.14 - $24.62 $62,910 - $169,459
6,883 Added 59.15%
18,519 $173,000
Q2 2023

Aug 14, 2023

BUY
$23.2 - $27.29 $59,693 - $70,217
2,573 Added 28.39%
11,636 $285,000
Q1 2023

May 15, 2023

BUY
$22.26 - $30.85 $201,742 - $279,593
9,063 New
9,063 $210,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $932M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.